Your compounded hormones may soon be taken away
The compounded hormones that cleared your brain fog and cooled your hot flashes? FDA is signaling they may soon restrict your access. it's time to speak up!
The review that NASEM was expected but failed to do
While limited in scope, a new meta-analysis of patient outcomes reveals that compounded hormones provide real benefits to patients and also find that compounded hormones pose no increased risk compared to FDA-approved products.
As part of its commission, NASEM was to review the body of patient-outcome studies for compounded hormones. NASEM chose to ignore that data, instead selecting only 13 studies to include in its report, mostly featuring hormones that are not among the most commonly prescribed. (Studies that matched their predetermined outcome?)
This report, published in Menopause, the journal of the North American Menopause Society, is exactly the kind of unbiased research that NASEM should have done but didn't.
"...compounded hormones provide real benefits to patients and finds that compounded hormones pose no increased risk compared to FDA-approved products."
Tell us your story then
share it with Congress
Congress has oversight of the FDA. It has the power to ensure that you keep access to your compounded hormones. Your representatives in the House and Senate need to know how compounded hormones have affected your life. And we've made it easy for you to tell them.
Follow the link. Use the pre-formatted email we've written, or write your story from your heart. Reach out to your representatives before the FDA takes drastic action.
Invest today to protect access to compounded hormones.
When the FDA signaled that it might severely restrict access to compounded hormones, we launched a campaign to raise awareness among patients, doctors and, especially, members of Congress.
When you contribute to this campaign — you are protecting access to this life-changing therapy for millions of patients.
